14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 125 days ( -2.62 % )
Last Price $26.68 0 %
High/ Low $26.68 - $26.68 0%
Chg 7 Days N/A $26.68 $26.68
Chg 30 Days N/A $26.68 $26.68
Chg 12 mos 58.53 % $16.83 $26.68
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos 116.15 % Width: 44.85 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos $47.97 - $69.49 79.80 % - 160.45 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Feb 25, 2022 - 100 days
Long MA avg 12 mos Buy Dec 17, 2021 - 147 days
Short/Long MA avg 12 mos Buy Dec 28, 2021 - 141 days
Pivot Short Sell Jul 19, 2022 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Zogenix

Zogenix Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders in the United States. The company’s lead product candidate is the ZX008, a low-dose fenfluramine for the treatment of seizures associated with Dravet syndrome. It also develops Relday, an injectable formulation of risperidone that is in Phase III clinical trial to treat the symptoms of schizophrenia and bipolar dis... ZGNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT